2-Linoleoylglycerol is a monoacylglycerol that acts as a CB1 receptor antagonist and partial agonist; it attenuates the activity of endocannabinoid ligands such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG) at CB1/CB2 receptors without enhancing their effects.